Does TILDRAKIZUMAB-ASMN Cause Off label use? 66 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 66 reports of Off label use have been filed in association with TILDRAKIZUMAB-ASMN. This represents 4.1% of all adverse event reports for TILDRAKIZUMAB-ASMN.
66
Reports of Off label use with TILDRAKIZUMAB-ASMN
4.1%
of all TILDRAKIZUMAB-ASMN reports
2
Deaths
0
Hospitalizations
How Dangerous Is Off label use From TILDRAKIZUMAB-ASMN?
Of the 66 reports, 2 (3.0%) resulted in death, and 1 (1.5%) were considered life-threatening.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TILDRAKIZUMAB-ASMN. However, 66 reports have been filed with the FAERS database.
What Other Side Effects Does TILDRAKIZUMAB-ASMN Cause?
Product dose omission issue (363)
Drug ineffective (223)
Psoriasis (86)
Death (84)
Product storage error (74)
Self-medication (74)
Condition aggravated (63)
Rash (54)
Pruritus (52)
Therapy cessation (50)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which TILDRAKIZUMAB-ASMN Alternatives Have Lower Off label use Risk?
TILDRAKIZUMAB-ASMN vs TILIDINE
TILDRAKIZUMAB-ASMN vs TIMOLOL
TILDRAKIZUMAB-ASMN vs TIMOLOL\TRAVOPROST
TILDRAKIZUMAB-ASMN vs TINIDAZOLE
TILDRAKIZUMAB-ASMN vs TINZAPARIN